In Brief
The cytokine IL-22 and inflammasomes are essential components of the mucosal responses to Candida albicans. Borghi et al. find that NLRP3-driven pathogenic inflammation during vaginal candidiasis is counteracted by IL-22 acting via IL1Ra. IL-1Ra deficiency in humans and mice leads to symptomatic infection, which is rescued by recombinant IL-1Ra.
INTRODUCTION
The ability to tolerate Candida albicans, a human commensal of the gastrointestinal tract and vagina, implies that host defense mechanisms of resistance and tolerance cooperate to limit fungal burden and inflammation at the different body sites. In the vagina, Candida species are the causative agents of vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC), two forms of disease that affect a large number of otherwise healthy women. Uncomplicated VVC is associated with several predisposing factors, whereas RVVC, marked by idiopathic recurrent episodes, represent a major therapeutic challenge. Whether a defective or exaggerated immune response toward Candida spp. is responsible for the symptoms in VVC is still being debated, but considerable evidence points to the association of recurrent episodes of symptomatic infection with immune hyperreactivity to the fungus (Fidel, 2007; Piccinni et al., 2002; Yano et al., 2012 ). An exaggerated and ineffective inflammation, revealed by a robust vaginal polymorphonuclear neutrophil (PMN) migration, occurs in susceptible women, promoting pathological inflammation without affecting fungal burden (Fidel, 2005; Peters et al., 2014b) . As PMN depletion protected mice from VVC (Peters et al., 2014a) , regulation of PMN recruitment and activity may need to be tightly controlled to prevent the state of nonresolving inflammation occurring during symptomatic infection.
By promoting PMN recruitment, IL-1 signaling essentially mediates local and systemic inflammation (Garlanda et al., 2013) . However, evidence also revealed the pathologic role of IL-1-mediated inflammation in a broad spectrum of human diseases, and pharmacological blockade of IL-1 activity in inflammatory diseases is beneficial (Dinarello et al., 2012; Dinarello and van der Meer, 2013) . IL-1b, IL-1a, and IL-18 contribute to host antifungal immune resistance (Bellocchio et al., 2004; Mencacci et al., 2000; Vonk et al., 2006) , and the inflammasome, a multiprotein complex whose formation results in activation of the cysteine protease caspase-1, is responsible for the activation of these cytokines from their inactive precursors (Joly and Sutterwala, 2010) . The transition from the yeast to the filamentous form of the fungus is sufficient (Gross et al., 2009; Hise et al., 2009; Joly et al., 2009) , although not essential (Wellington et al., 2012 (Wellington et al., , 2014 , for NLRP3 (Nod-like receptor family, pyrin domain containing 3) inflammasome activation. The yeast-to-hypha transition is also required for IL-1b, pyroptosis, and PMN recruitment that is associated with the transition from benign colonization to symptomatic infection in vaginal candidiasis (Peters et al., 2014a) . Thus, as in orogastric candidiasis (Gross et al., 2009; Hise et al., 2009) , NLRP3 is likely activated in VVC (Bruno et al., 2015) . Indeed, NLRP3, in either the hematopoietic or stromal compartments, and epithelial NLRC4 both played an important role in immune resistance to oral candidiasis (Tomalka et al., 2011) . IL-22 is known to mediate anticandidal resistance at mucosal surfaces under conditions of defective adaptive immunity (Zelante et al., 2011) , an activity to which the local microbiota crucially contributes (Zelante et al., 2013) . Sensing of tissue damage via the NLRP3 or NLRP6 increased the ratio of IL-22/ IL-22 binding proteins (IL-22BP) via an IL-18-dependent downregulation of IL-22BP, thereby linking the activity of IL-22 to inflammasome activation (Huber et al., 2012) . Whether, however, IL-22 exerts a control over inflammasome activity is not known.
In the current study, we evaluated the role of IL-1 signaling, the relative contribution of different inflammasomes, and the regulation by IL-22 in murine and human VVC. We found that NLRP3 activation contributed to neutrophil recruitment and inflammation in infection, an activity counteracted by IL-22. Mechanistically, IL-22 promoted the activity of NLRC4 on epithelial cells, resulting in the sustained production of the IL-1 receptor antagonist, IL-1Ra, capable of restraining NLRP3 activation. Symptomatic infection in mice and humans occurred in conditions of IL-1Ra deficiency and rescued in mice by replacement therapy with the IL-1Ra anakinra. These results indicate that pathogenic inflammasome activity in vaginal candidiasis is negatively regulated by the IL-22/NLRC4/IL-1Ra axis and offer insights in the pathogenesis and therapy of vaginal candidiasis.
RESULTS

Inflammasome Activity in Vaginal Candidiasis
To evaluate inflammasome activity in murine VVC, we intravaginally infected C57BL/6 mice with Candida blastospores and measured caspase 1 cleavage; lactate dehydrogenase (LDH) activity; and IL-1b, IL-1a, and IL-18 production during infection. Despite the ability of these mice to eventually control infection and inflammation, fungi and PMN infiltrating the vaginal parenchyma with signs of epithelial damage at the early stages of the infection have been described . We found here that the levels of the cleaved fragment of procaspase-1 ( Figure 1A ) and LDH ( Figure 1B ) increased during the first week of the infection, and steadily declined thereafter to reach control levels at 3-4 weeks after the infection. All the cytokines were detected at the protein (in the vaginal fluids, VFs) and mRNA (in vaginal tissue) levels during infection, with IL-1b and, even more, IL-1a being maximally produced through the first 2 weeks of the infection. IL-18, in contrast, showed a bimodal peak production, being observed early but also late in infection ( Figures 1C and D) . Blocking IL-1b, more than IL-1a or IL-18, by means of neutralizing antibody (see Figure S1A available online) greatly reduced PMN recruitment, as revealed by vaginal histopathology ( Figure S1B ) and vaginal expression of Mpo, S100a8, and S100a9 mRNA ( Figure S1C ). These results indicate that inflammasome activity is present in mice with symptomatic candidiasis and contributes to PMN recruitment.
NLRP3 and NLRC4 Are Nonredundantly Activated in Vaginal Candidiasis
We next assessed whether and which members of the inflammasome family are activated during VVC. To this purpose, we measured protein and gene expression of NLRP3 and NLRC4, for their involvement in mucosal candidiasis (Tomalka et al., 2011) . As revealed by immunofluorescence and immunohistochemistry staining of vaginal tissues, NLRP3 expression was robust during the first week of the infection on cells of the keratinized epithelium (EC) as well as on recruited PMNs, to decline thereafter ( Figure 1E , and magnified in the insets). The expression of NLRC4 persistently increased during infection and mostly on EC ( Figure 1E ). However, as phosphorylation on Ser 533 is required for NLRC4 activity (Qu et al., 2012) , we did immunostaining with a specific anti-phospho-(p)NLRC4 antibody to reveal that pNLRC4 expression also increased in infection and paralleled that of NLRC4. Gene ( Figure 1F ) and protein (Figure 1G ) expression analysis by RT-PCR and western blotting, respectively, confirmed that NLRP3 was maximally expressed early in infection, whereas pNLRC4 activation occurred early but, even more, 2 weeks later. These results indicate that multiple inflammasomes are activated in infection and, interestingly, that NLRC4 activation and NLRP3 inhibition are temporally coincident.
NLRP3 Contributes to Pathogenic Inflammation in VVC in the Absence of NLRC4
To unravel the functional activity of either NLRP3 or NLRC4 in VVC, we assessed Nlrp3 -/-or Nlrc4 -/-mice for susceptibility to infection and inflammasome activity. Nlrp3 -/-mice, although not clearing the infection as efficiently as wild-type (WT) mice (Figure 2A ), had lower PMN ( Figure 2B ) and less vaginal immunopathology ( Figure 2C ) than WT mice. Caspase-1 activation (Figure 2D ), LDH activity ( Figure 2E ), and IL-1b production ( Figure 2F ) were similarly lower in Nlrp3 -/-than WT mice. Accordingly, the levels of IL-17A and IL-17F ( Figure 2G ) were lower in Nlrp3 -/-than Nlrc4 -/-mice. Of great interest, immunofluorescence staining ( Figure 2C ) and western blotting analysis ( Figure 2H ) of Nlrp3 -/-vagina, while negative for NLRP3 expression, showed an exuberant pNLRC4 expression. These data suggest that NLRP3, more than NLRC4, may contribute to caspase-1 activation, PMN infiltration, and inflammatory damage in VVC. The unexpected resistance of Nlrp3 -/-mice to vaginal immunopathology, along with the remarkable expression of pNLRC4, would suggest that NLRC4 could be involved as an alternative upstream sensor that limits inflammation. The results in Nlrc4 -/-mice showed that this is indeed the case, as these mice, while controlling the fungal growth as efficiently as WT mice (Figure 2A) , showed a massive infiltration of PMN ( Figure 2B ), vaginal immunopathology ( Figure 2C ), inflammasome activation ( Figures 2D-2G) , and huge NLRP3 expression ( Figures 2C and H) . Consistent with the findings that inflammasomes contribute to antimicrobial peptide production in oral candidiasis (Tomalka et al., 2011) and lipocalin 2 expression correlated with protection in VVC (Zelante et al., 2013) , we found an upregulated expression in infection of the Mbd1-4 and Lcn2 (encoding for lipocalin 2) genes ( Figure S2A ) that was either dependent (Mbd1,2,4) or independent (Mbd3) from both NLRP3 and NLRC4 or strictly dependent on NLRC4 only (Lcn2). These results suggest that NLRP3 and NLRC4, despite overlapping functions, may have a distinct role in murine VVC. NLRP3 activation on EC and myeloid cells may contribute to fungal clearance but also to inflammation in the relative absence of NLRC4. As such, these findings are different from those observed in oral candidiasis (Tomalka et al., 2011) , in which NLRC4 more than NLRP3 contributed to PMN recruitment. 
(legend continued on next page)
However, further experiments in bone marrow chimera mice confirmed that PMN recruitment ( Figure 2I ) and inflammation ( Figure 2J ) were lower, and fungal burden higher ( Figure 2K ), in Nlrp3
-/-mice. Moreover, PMN recruitment and inflammation were similarly low, and the fungal burden high, in the vaginas of WT or Nlrc4 À/À infected mice upon NLRP3 inhibition by siRNA ( Figure S3 ). Thus, confirming the distinct host immune defenses against oral and vaginal candidiasis (Fidel, 2002) , NLRP3 contributes to inflammatory cell recruitment and inflammation in murine VVC, an activity counteracted by the activation of NLRC4 on EC.
Further experiments in mice with a high or low inflammasome activity, such as Tir8 -/-and Il1r1 -/-mice, respectively, demonstrated that NLRP3 activation contributes to vaginal pathology. SIGIRR/TIR8-a member of the IL-1R family acting as a negative regulator of TLR/IL-1R signaling-is required for host resistance to fungal infections and functions to negatively regulate IL-1b-dependent activation of inflammatory Th17 responses (Bozza et al., 2008 Figure 3C ), caspase-1 activation ( Figure 3D ), and IL-1b production ( Figure 3E ) in Tir8 -/-as compared to Il1r1 -/-mice. NLRP3 expression was robust in Tir8 -/-mice, while pNLRC4 expression occurred in
Il1r1
-/-mice, as revealed by immunostaining ( Figure 3C ), gene ( Figure 3F ), and protein ( Figure 3G ) expression.
IL-22 Activates Protective NLRC4 in Response to
Candida In light of the above results, we searched for possible mechanisms behind NLRC4 activation and its regulation of NLRP3 activity. Because signs of vaginal epithelial damage and inflammation and robust PMN recruitment were present in the relative absence of IL-22 (De Luca et al., 2013; Yano et al., 2012) , we hypothesized that phosphorylation of NLRC4 could represent a mechanism through which IL-22 may provide antifungal resistance with limited pathology in infection. To this purpose, we assessed parameters of inflammasome activity as well as NLRP3 or pNLRC4 expression in intravaginally infected Il22 -/-mice. Similar to C57BL/6 mice, IL-1b production ( Figure 4A ) and caspase-1 cleavage ( Figure 4B ) were activated in Il22 -/-mice.
However, NLRP3, but not pNLRC4, was activated in infection, as revealed by vaginal expression of either inflammasome (see Figures 4C and 4D and Figure 1 for comparison). This suggests that NLRC4 failed to be phosphorylated in the absence of IL-22. NLRC4 is activated upon phosphorylation at Ser533 by protein kinase C d (PKCd) (Qu et al., 2012) , a member of the serine/threonine protein kinases family considered key signaling mediators in the process of inflammation (Reyland, 2009) . PKCd also phoshorylates STAT3 (Litherland et al., 2010) , a transcription factor regarded as the principal and dominant mechanism of cellular activation by IL-22 (De Luca et al., 2010) . We therefore assessed whether IL-22 would be able to phosphorylate NLRC4 via PKCd by exposing vaginal cultures to different stimuli, including flagellin, a known activator of the neuronal apoptosis inhibitor protein (NAIP)5-NLRC4 pathway (Zhao et al., 2011) in the presence of IL-22. We found that flagellin ( Figure 4E ) and live Candida cells + LPS, but not LPS or Candida alone ( Figure 4F ), activated PKCd. IL-22 greatly increased PKCd activation in response to flagellin, an activity counteracted by the PKCd inhibitor rottlerin ( Figure 4E ), and activated PKCd in response to Candida + LPS and, of great interest, to Candida alone ( Figure 4F ). IL-22 also induced STAT3 phosphorylation (data not shown) and the expression of Nos2 (Figure 4G ), which is known to be positively regulated by PKCd (Leppä nen et al., 2013) . Of interest, IL-22 also increased IL-1Ra in vaginal cultures, irrespective of NLRP3 (Figure 4H) . These data suggest that IL-22 is required for NLRC4 phosphorylation in response to Candida via PKCd. Confirming the upstream role for IL-22/PKCd in NLRC4 activation, IL-22 administration in vivo upregulated pNLRC4 and Lcn2 expression and decreased cytotoxic damage in the vaginas of infected mice ( Figure 4I ). In contrast, treatment with rottlerin, known to mimic PKCd inhibition (Soltoff, 2007) , while inhibiting PKCd ( Figure 4J ), decreased pNLRC4 expression and increased NLRP3-associated inflammation ( Figure 4K ) and PMN recruitment ( Figure 4L ).
Rottlerin was ineffective in Il22
-/-mice (data not shown), a finding indicating that IL-22 is required for PKCd activation in infection. Therefore, in vitro and in vivo evidence point to a functional role of the IL-22/PKCd axis in NLRC4 activation in murine VVC. Further confirming this, the aryl hydrocarbon receptor/IL-22 axis was much upregulated in conditions of high pNLRC4 expression, such as in Nlrp3 -/-mice (from 27 ± 5 to 69 ± 7 pg/ml IL-22 levels in the vagina of C57/BL6 versus Nlrp3 -/-mice, at 3 dpi).
NLRC4 Dampens Pathogenic NLRP3 Activity via IL-1Ra
IL-1Ra is a potent suppressor of inflammasome activity (Petrasek et al., 2012) . Although most intracellular IL-1Ra remains in the cytoplasm of cells, some isoforms may be released from EC in some conditions and may function as extracellular receptor antagonists of IL-1RI (Levine et al., 1997) . We measured IL-1Ra production in vivo during infection and found a dichotomous pattern of production that correlates with levels of immunopathology in mice with vaginal candidiasis. It was increasingly produced in more resistant WT, Nlrp3
, and Il1r1 -/-mice, reaching a peak level at around 2 weeks, but only produced early in infection with a sharp decline thereafter in conditions of inflammatory pathology, such as in Tir8
, and Il22 -/-mice ( Figure 5A ). Thus, a sustained IL-1Ra production appears to be required for successful control of inflammation during infection, an activity for which IL-22 and NLRC4 are required. Experiments carried out in Il1ra -/-(E) Periodic acid-Schiff-staining, immunohistochemistry (scale bars, 100 mm), and immunofluorescence staining (scale bars, 25 mm) of vaginal sections with antibodies to NLRP3, NLRC4, and p (phospho) NLRC4. Sections were stained with the relevant primary antibody overnight at 4 C followed by secondary biotinylated or fluorescent antibodies. Images were acquired with a 403 objective and the analySIS image processing software. Insets, 1003 objective. 4 0 -6-Diamino-2-phenylindole was used to counterstain tissues and to detect nuclei.
(F and G) (F) Gene and (G) protein analysis (RT-PCR and western blotting, respectively) on ex vivo vaginas. Data (mean ± SD) are pooled or representative (histology/immunostaining/western blotting) from four independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, infected versus uninfected (dpi 0) mice. See also Figure S1 .
mice confirmed the protective role of IL-1Ra in infection. Signs of an exaggerated inflammatory response ( Figure 5B ), likely accounting for the restrained fungal growth ( Figure 5C ), huge PMN recruitment even before the infection ( Figure 5D ), caspase-1 cleavage ( Figure 5E ), and LDH release ( Figure 5F ), were all observed in Il1ra -/-mice along with a robust NLRP3, but not pNLRC4, expression ( Figure 5G ). Of great interest, treatment with anakinra decreased the fungal growth ( Figure 5C ), PMN recruitment ( Figure 5D ), vaginal inflammation ( Figure 5B ), and tissue damage ( Figure 5F ) in both WT and Il1ra -/-mice. These results point to a possible protective role of IL-1Ra in murine VVC, such that exogenous supply of anakinra could be of therapeutic value. 
IL-22 Activates NLRC4 in Response to Candida in Human Vaginal Cells
Based on these findings, and to recapitulate the murine data, we assessed NLRP3 and pNLRC4 expression in the human HeLa cell line exposed to germinated Candida cells in the presence of IL-22 and/or PCKd inhibition by siRNA and measured levels of IL-1b, IL-1Ra, and IL-22 in human RVVC. Confirming the murine findings, pNLRC4, but not NLRP3, expression was increased by IL-22 in response to Candida or flagellin used as a positive control ( Figure 6A ), in a PKCd-dependent manner. In fact, IL-22 activated PKCd in response to Candida (Figures 6B and 6C ) and PKCd inhibition prevented the activation of NLRC4 ( Figure 6D ). Similar results were obtained with the vulvovaginal A431cells ( Figure S4 ). In terms of cytokine profile, high levels of IL-1b and low levels of IL-1Ra and IL-22 were observed in the VF of patients with RVVC ( Figure 6E ). Altogether, these data provide evidence that NLRP3 and NLRC4 are likely activated in the human infection where a defective production of IL-1Ra and IL-22 may be a risk factor for RVVC.
DISCUSSION
The present study shows that NLRP3 and NLRC4 are activated in vaginal candidiasis, play a non redundant role in infection, and are orchestrated by IL-22. Our results confirm previous observations obtained in the orogastric model of infection in which NLRP3 was required to prevent the systemic dissemination of mucosal infection while NLRC4 was locally protective (Tomalka et al., 2011) . At variance with that study, we found that NLRP3, more than NLRC4, contributed to PMN recruitment in infection, a finding confirming major tissue-specific differences in innate immune antifungal pathways (Bruno et al., 2015; Fidel, 2002) . Similar to that study, we found that functional NLRC4 activity in ECs is required for protection to mucosal candidiasis. The protective action of NLRC4 in intestinal infections (Franchi et al., 2012; Nordlander et al., 2014 ) is mostly carried out in cooperation, if not redundantly (Broz et al., 2010) , with NLRP3 (Broz et al., 2010; Man et al., 2014) to drive robust IL-1b signaling (Broz et al., 2010; Man et al., 2014) . We instead found that either inflammasome plays a distinct role in vaginal infection. Via caspase-1 cleavage and IL-1b production, NLRP3 activation contributed to neutrophil recruitment and inflammation in infection, a finding suggesting that regulation of NLRP3 activity is required for the proper control of the inflammatory pathology associated with mucosal Candida infections. Indeed, we found that NLRP3-dependent PMN infiltration and inflammation were associated with disease severity in conditions of unrestrained NLRP3 activity, such as those observed in highly susceptible Tir8
-/-mice. Of interest, despite experiencing a similar degree of inflammatory pathology, the fungal growth was different in these mice, a finding suggesting the contribution of receptors other than inflammasomes in restraining the fungal growth. In contrast, despite an initial high fungal burden, disease severity was minimal in Il1r1 -/-mice and correlated with defective NLRP3 activity. Thus, the limited inflammatory pathology observed in Il1r1 -/-mice not only recapitulates what has been already observed in gastrointestinal candidiasis (Bellocchio et al., 2004; Bozza et al., 2008) but also points to the existence of a thigh control of NLRP3 activity upon the exposure to the fungus. While it is conceivable that the net functional activity of NLRP3 in infection is also contingent upon the fungal load, we have found that NLRC4 fine-tunes NLRP3 activity in candidiasis. NLRC4 has been implicated in a proinflammatory defense mechanism in the intestine against foreign, but not commensal, bacteria (Franchi et al., 2012; Nordlander et al., 2014) . It has also been proposed that NLRC4 activation can be detrimental after antibiotic treatment that severely alters the composition of microbiota (Ayres et al., 2012) . We showed here that Nlrc4 -/-mice developed a severe disease and inflammatory response that was concomitant with NLRP3 activation, which suggests that, in addition to defensin production, NLRC4 acts as a negative regulator of NLRP3 activity. The IL-1/NRLP3 pathway is tightly controlled via a number of positive and negative regulators (Latz et al., 2013) . In response to Candida, type I interferon via STAT1 or IL-10 via STAT3 inhibited NALP3 activity (Guarda et al., 2011) . We found that IL-1Ra, a potent suppressor of inflammasome activity (Petrasek et al., 2012) , also blocked NLRP3 in response to the fungus. Although typically secreted by monocytes and PMN, bioactive IL-1Ra isoforms could be released from EC in some conditions and may represent a mechanism by which IL-1 bioactivity is locally modulated (Levine et al., 1997) .
Accordingly, EC expressing NLRC4 likely contributed to the sustained production of IL-1Ra that discriminates between resistance and susceptibility to the infection. Somehow unexpected, NLRP3 was apparently unable to contribute to sustained IL-1Ra production. In search for a plausible explanation for this phenomenon, the fact that caspase-1 is able to cleave the TRIF (H) IL-1Ra levels (pg/mg, cytokine/total proteins, mean ± SD) in vaginal culture supernatants. (I) NLRP3 and pNLRC4 expression (immunofluorescence staining), Lcn2 expression (RT-PCR), and LDH activity (% cytotoxicity) (7 dpi) in the vaginas of infected C57BL/6 mice intravaginally treated with IL-22. Control mice received PBS. *p < 0.05, Il22 -/-mice versus WT mice, and treated versus untreated.
(J-L) (J) Immunoblotting of PKCd in vaginal lysates, (K) vaginal pathology (periodic acid-Schiff-staining of sections; scale bars, 100 mm), and immunofluorescence staining with NLRP3 and pNLRC4 antibodies (scale bars, 25 mm) and (L) PMNs quantification (by nuclear morphology) in VF of infected mice treated with rottlerin. Control mice received PBS. Data (mean ± SD) are pooled or representative (histology/immunostaining/western blotting) from three independent experiments. *p < 0.05, treated versus untreated mice.
adaptor, thus limiting TRIF signaling, could be a possible explanation (Jabir et al., 2014) . Indeed, TRIF signaling was required not only to eventually restrain the inflammatory response in VVC but also to sustain IL-1Ra production in infection (unpublished data). This may explain the relative loss of IL-1Ra in conditions of sustained caspase-1 activation, such as that occurring downstream NRLP3, and less, NLRC4 signaling. Therefore, NLRC4 contributes to sustained production of IL-1Ra to restrain pathogenic inflammasome activation in infection. NLRC4 is specifically activated by a functional bacterial type III or IV secretion system (T3SS/T4SS) or flagellin (Miao et al., 2010; Zhao et al., 2011) . Ligands are believed to directly bind distinct members of the NAIP NLR subfamily to subsequently activate the NLRC4 inflammasome (Kofoed and Vance, 2011) . Evidence shows that NLRC4 is activated upon phosphorylation at Ser533 by PKCd (Qu et al., 2012) , a known regulator of inflammation via the iNOS pathway (Leppä nen et al., 2013) . PKCd is a ubiquitously expressed isoform of PKC that is subject to phosphorylation on tyrosine residues by a variety of stimuli, particularly after activation of cells by growth factor receptors (Denning et al., 1996) . Germinated Candida cells, known to activate NLRP3 (Gross et al., 2009; Hise et al., 2009) , were unable to activate NLRC4 phosphorylation on ex vivo vaginas and on vaginal human ECs. However, they did so in the presence of IL-22. It is of interest that PKCd contributes to skin homeostasis (Koppel et al., 2014) and also phoshorylates STAT3 (Litherland et al., 2010) , a transcription factor regarded as the dominant mechanism of cellular activation by IL-22 (De Luca et al., 2010) . Thus, similar to other microbes (Taxman et al., 2010) , Candida has devised a strategy to manipulate the inflammasome function and downstream signaling to avoid inflammation with the complicity of IL-22. This implies that IL-22, known to mediate early anticandidal resistance at mucosal surfaces (Zelante et al., 2011) , also functions as a danger signal capable of activating epithelial NLRC4 to restrain inflammation to the benefit of the host but also of the fungus, given that inflammation promotes fungal virulence (Zelante et al., 2012) . It is quite likely that IL-18, via downregulation of IL-22BP (Huber et al., 2012) , may influence the temporal activity of IL-22 in infection, thus offering a plausible explanation for the temporally coincident IL-18 production and NLRC4 activation.
Overall, the data of the present study further add to the biological functions of IL-22 in C. albicans infection that include a previously undescribed control over pathogenic inflammasome activation via the PKCd/NLRC4/IL-1Ra axis (Figure 7) . Given the ability of IL-22 to regulate IL-1Ra production, our findings may explain why genetic deficiency of IL-22 (De Luca et al., 2013) contributes to the low IL-1Ra activity in RVVC. As such, these findings may offer insights in the pathogenesis and therapy of vaginal candidiasis. Not only could the IL-1b and IL1Ra levels be used as a biomarker of disease susceptibility, but anakinra may prove to be a therapeutic agent in RVVC. In contrast to anti-TNF approaches, whose utility was compromised by infectious complications, administration of IL-1Ra has demonstrated an excellent safety profile, and its use has not been associated with adverse reactions or superinfections with long-term treatment (Dinarello et al., 2012) . Our study shows that the elucidation of pathogenetic mechanisms at the molecular level may lead to the development of approaches toward controlling inflammasome-dependent inflammatory and infectious processes.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in the Supplemental Experimental Procedures. Assays were done at 7 dpi. Data (mean ± SD) are pooled or representative (histology/immunostaining/western blotting) from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, [2015] [2016] [2017] [2018] [2019] [2020] . The human study approval was provided by the University Ethics Committee of Perugia (Prot. 2012-028) , and informed written consent was obtained from all participants for genetic and functional assessments.
Patients and Control Subjects
The study population included Caucasian women recruited at the S. Maria della Misericordia Medical Center (Perugia, Italy), Wayne State University School of Medicine (Detroit, MI, USA), and Radboud University Nijmegen Medical Center (Nijmegen, The Netherlands) and diagnosed with at least three documented episodes of VVC in a year; control subjects consisted of age-matched healthy Caucasian women with no gynecologic complaints, no history of vaginal Candida infection, and who were currently culture negative for vaginal pathogens Figure S4 .
preparations of the lavage fluids were stained with May-Grü nwald-Giemsa. For histology, the vaginas sections were stained with periodic acidSchiff reagent. The BX51 microscope equipped with a high-resolution DP71 camera (Olympus) was used. Mice received 10 mg of cytokine neutralizing antibodies intravaginally from the day of the infection until the end of the experiment; 1 mg of recombinant IL-22 intravaginally, the day of the infection and 1 and 2 days after; 10 mg/kg of anakinra intraperitoneally, daily for 7 days, starting the day of the infection; and 10 mg of rottlerin intravaginally, the day before, the day of the infection, and 1 day later. Control mice received PBS.
SiRNA Cells were transfected with 25 nM siRNA or equivalent doses of nonspecific control siRNA using Lipofectamine 3000 Reagent (Life technologies). Mice received 10 mg/kg of siRNA intravaginally, the day before infection, and 1 and 2 days after infection.
Generation of Chimera Mice
Lethally irradiated mice (exposed to a Cesium-139 c-radiation source for a total full body dose of 700 rads) received 6 3 10 6 bone marrow cells from pooled donor mice via tail vein injection and allowed to recover for 4 weeks.
Pyropoptosis
Pyropoptosis was assessed by LDH Cytotoxicity Assay Kit (Abcam).
Cell Cultures
HeLa, A431 human cells, and vaginas from untreated mice were exposed to 10 mg/ml LPS (1 hr pretreatment) + 5 mM nigericin, 5 mg/ml flagellin, 10 mM rottlerin (1 hr pretreatment) or germinated live C. albicans (cells:fungi ratio of 1:1), in the presence of 20 ng/ml of IL-22 for 4 hr before assays.
Immunofluorescence and Immunohistochemistry Staining
Vaginal sections and human cells were stained overnight at 4 C with anti-Nlrp3 (Abcam) or anti-Nlrc4 (Millipore) antibodies followed by secondary TRITC antibodies. Anti-Nlrc4-P (Genentech) followed by anti-hamster FITC (Sigma) was used for pNLRC4. For immunohistochemistry, sections were incubated overnight with polyclonal anti-Ipaf (NLRC4) (Millipore, Darmstadt, Germany) or anti-CIAS1/NALP3 antibody (Abcam, Cambridge, UK), followed by the secondary biotinylated antibodies. In order to highlight the NLRP3 cytoplasmic localization, cells were also stained with phalloidine (Alexa Fluor 488 dye). 4 0 -6-diamino-2-phenylindole (DAPI, Molecular Probes) was used to counterstain cells and to detect nuclei. Images were acquired using a microscope (BX51 Olympus) with a 403 objective and the analySIS image processing software.
Western Blotting
Blots of cell lysates were incubated with rabbit anti-murine Caspase-1 p10 (Santa Cruz Biotechnology), goat polyclonal anti-Nlrp3 (Sigma), anti-Nlrc4 (Millipore), anti-Nlrc4-P (Genentech), and rabbit polyclonal anti-PKC delta (phospho-T505) antibodies (Abcam) followed by horseradish peroxidase-conjugated secondary IgG. Images were acquired with LiteAblotPlus chemiluminescence substrate (Euroclone S.p.A.), using ChemiDoc XRS and Imaging system (Bio-Rad Laboratories).
ELISA and Real-Time PCR
The levels of murine and human cytokines and chemokines were determined by Kit ELISA (eBioscience Kit ELISA and R&D Systems). Data were normalized to total protein levels for each sample as determined using the Bio-Rad Protein assay (Life Science, Bio-Rad Laboratories S.r.l. Milan Italy) and expressed as pg cytokine/mg total protein. Results represent mean cytokine levels (±SD) from samples pooled from two similar experiments (n = 3-4 total samples per group). Real-time PCR was performed using the iCycler iQ detection system (Bio-Rad) and SYBR Green chemistry (Finnzymes Oy) on total RNA extracted using RNeasy Mini Kit (QIAGEN, Milan, Italy) and reverse transcribed with Sensiscript Reverse Transcriptase (QIAGEN). The PCR primers were as described (De Luca et al., 2010) . Amplification efficiencies were validated and normalized against Gapdh. The mRNA-normalized data were expressed as relative mRNA in knockout versus WT mice and infected versus naive mice.
Statistical Analysis
Student's t test or analysis of variance (ANOVA) with Bonferroni's adjustment was used to determine statistical significance (p < 0.05). The data reported are either from one representative experiment out of three to five independent experiments (western blotting and RT-PCR) or otherwise pooled from three to five experiments. The in vivo groups consisted of 6-8 mice/group. Data were analyzed by GraphPad Prism 4.03 program (GraphPad Software). Genotype distributions among controls and VVC and RVVC patients were analyzed by Fisher's exact test. 
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